Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for October 2007
October 1, 2007
- Teva Announces Court of Appeals Denies Novartis' Emergency Motion on Generic Famvir
- Eisai Announce Application to Appeal NICE Judicial Review Verdict
- AstraZeneca Appoints Chief Financial Officer
- Kissei and Eisai Sign a License Agreement to Develop and Commercialize Glufast, a Rapid-acting Insulin Secretagogue in China
- Mitsubishi Tanabe Pharma Corporation Announces Its Establishment
- Roche Confirms Site Development Plans: Go-Ahead for Office High-Rise
- Shire to Support Appeal Against Outcome of Judicial Review of NICE Guidance Which Denies Newly Diagnosed Patients with Mild Alzheimer's Disease Access to Drugs on the NHS
- Bristol-Myers Squibb to Pay More Than $515 Million to Resolve Allegations of Illegal Drug Marketing and Pricing
- Mylan Announces Extension of Tender Offers for Its 5.750% Senior Notes due 2010 and 6.375% Senior Notes due 2015
- Amgen Provides Update on Late-Stage and Early-Stage Pipeline at UBS Global Life Sciences Conference
- Addex Pharmaceuticals Announces ADX10061 Phase IIa Smoking Cessation Data
- Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize
- FivePrime Achieves Target Discovery Milestone With Boehringer Ingelheim
- Chemizon Announces Research Collaboration Expansion With Takeda
- GE and Lilly Announce Research Collaboration to Co-Develop Molecular In Vitro Diagnostics for Cancer Treatments
- AmerisourceBergen Acquires Bellco Health for $190 Million
- PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets
October 2, 2007
- Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
- FDA - MedWatch - Early Communication Issued Regarding Atrial Fibrillation With Oral And Intravenous Bisphosphonates
- Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc.
- Mylan Completes Acquisition of Generics Business of Merck KGaA
- Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
- Mylan Announces Appointment of John Montgomery as President, Asia Pacific
- Mylan Appoints Rajiv Malik as Executive Vice President, Head of Global Technical Operations
- Lilly's CEO Calls for Reform of Nation's Drug Safety System
October 3, 2007
- Pediatric Asthma Programs With CyDex Captisol Technology Acquired by AstraZeneca
- Watson Files Application for Generic FEMCON Fe
- FDA Sends Letter to Lilly Over Cymbalta Mailer
- Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
- Arsenal Capital Announces Sale of Priority Solutions to Thermo Fisher Scientific
- Cangene Consolidating R&D Operations
- FDA Acts to Ensure Thyroid Drugs Don’t Lose Potency Before Expiration Date
October 4, 2007
- More than 40% of US Physicians Report Improved Services from Pharma, with Merck Rated Highest on Delivering Quality Sales and Service Experiences
- Dr. Martin Mackay Named President of Pfizer Global Research and Development
- Children's Aching Stomachs: New Research Finds Young Children are Increasingly Using Medications to Treat Gastrointestinal Ailments
- Amgen to Postpone Indefinitely Its Plans for a Manufacturing Facility in Ireland
- Announcement of the Launch of Geninax Tablet, an Oral New-Type Quinolone Antibacterial Agent, in Japan
- GSK Seeks Prequalification for Cervarix from the World Health Organization After Obtaining Marketing Approval in Europe
- Novartis Pharmaceuticals Canada Inc. Complies with Request from Health Canada to Withdraw Prexige (lumiracoxib) in Canada
- Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc.
- FDA Announces Initiative to Bolster Generic Drug Program
- FDA Seeks Nominations for Reagan-Udall Foundation
- FDA Takes Next Step in Transformation of its Center for Drug Evaluation and Research
- Bioject Announces Roche and Trimeris Update on the Use of Fuzeon with Biojector 2000
October 5, 2007
- Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
- Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
- Mylan Settles Its First-to-File Opportunity on Levetiracetam with UCB
- Avesthagen-CIPLA JV Acquires State of the Art Biological Company in Germany
- Northbank Communications Joins College Hill
- Navamedic ASA (NO) - Initiates a New Strategic Phase - Navamedic ASA Completes the Acquisition of Vitaflo Scandinavia AB
- Aptivus (tipranavir) Capsules Granted Full Approval by the U.S. FDA
- Merck Wins Product Liability Case in Florida Circuit Court
October 8, 2007
- GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
- Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
- Shire Divests Non-Core Product Portfolio to Almirall
- Asuragen Licenses Roche's Real-time Quantitative PCR Technology for Clinical Gene Expression Profiling
- GlaxoSmithKline Appoints Andrew Witty CEO Designate
- Bavarian Nordic Receives USD 50 Million Advance Payment from the U.S. Government for Fulfilling Contract Milestones
- Almirall Acquires a Portfolio of Eight Products from Shire Plc for $213 Million
- ICC Purchases UK Agency; Strengthens European Presence
October 9, 2007
- EPO Rules European Nexium Process Patent Valid
- NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Million to Support Late-Stage Product Development
- ForSight Labs Announces Acquisition of ForSight Newco II by QLT, Inc.
- Biomax Informatics AG Licenses the BioRS Integration and Retrieval System to Boehringer Ingelheim
- Lafley Tells Shareholders That 'P&G is Designed to Grow'
- NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Million to Support Late-Stage Product Development
- Acusphere Statement
- Global Access Project (GAP) Study Examining Patients' Cancer Care Experiences Featured in Journal CANCER
October 10, 2007
- GlaxoSmithKline and Synta Pharmaceuticals Announce Development and Commercialization Collaboration for STA-4783 in Oncology
- Bioenvision and Genzyme File Petition in Delaware Court
- Health Care Merger and Acquisition Activity Strong in Third Quarter 2007, Year Already Second-Largest Ever in Health Care M&A According to New Report from Irving Levin Associates, Inc.
- Medication Shows Promise as a Treatment for Alcohol Dependence
- DARA BioSciences and Point Therapeutics Announce Merger Plans
- Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies
- Iowa AG Sues 78 Drug Companies for Overcharging Iowa Medicaid
- Sales of Etimicin Sulfate to Expand Nationwide as Government Restriction is Lifted
- Taisho Revises Earnings Forecasts for FY2007 First Half and Full Year
- Lupin Acquires in Japan
- Delaware Court Approves Bioenvision, Genzyme Joint Petition
October 11, 2007
- Publicis Groupe Strengthens its Leadership in Digital and Integrated Healthcare Communications in Italy
- Karo Bio to Focus its Operations
- HER-2 Status Predicts Success of Chemotherapy in Breast Cancer Treatment, Study Finds
- Cholesterol-Lowering Drugs Cut Heart Attacks by More Than a Quarter
- Daiichi-Sankyo to Install Corning Epic System
- Verispan's Vector One: Higher than Average GERD Market Growth in Hispanics
- FDA Advises Cochlear Implant Patients Be Vaccinated
- Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
October 12, 2007
- MAb sector growth will continue to far outstrip that of small molecules
- Harvard Bioscience Acquires Panlab s.l. Establishing a Spanish Subsidiary and Expanding Access in the Neuroscience Research Market
- Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of Azor
- PerkinElmer Commences Cash Tender Offer for ViaCell
- ConsumerLab.com Finds Generic Antidepressant Behaves Differently from Original Drug May Explain Complaints by Patients
- Patients Can't Recall Their Medications to Tell Doctors
- Dong-A Pharmaceutical Co Ltd (000640 Ks) Urges Shareholders to Vote Against the Kang-Korea Alcohol Nominees at the Oct. 31 EGM
- Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
October 15, 2007
- Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb
- FDA Removes Partial Hold on Telcyta Clinical Development
- Pfizer Engages with Nation's Physicians Through Sermo to Improve Patient Care
- Orexo to Acquire Biolipox - Building a Specialty Pharma Company Driven by Innovation
- Biogen Idec Issues Statement
- HealthiNation Delivers On Demand Health Programming to Verizon FiOS TV Subscribers
- European Medicines Agency Sees Strong Level of Applications in 2007
- Biopure Announces Expanded Clinical Program to Target Anemia
- Sartorius Sells Hydrodynamic Bearings Business to the British Smiths Group
- Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
- Celera Completes Acquisition of Berkeley HeartLab, Inc.
- Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin Sensitivity Test
October 16, 2007
- Camelot Ventures Sells RealAge to Hearst Magazines
- Johnson & Johnson Reports 2007 Third-Quarter Results: Sales of $15.0 Billion Increased 12.7%; EPS was $.88, Including Special Charges; Excluding Special Charges, EPS was $1.06 *
- Wyeth to Appeal Nevada Hormone Therapy Trial Verdict
- Genentech Announces Third Quarter 2007 Results
- Strong Sales Growth in the First Nine Months of 2007 - Full-year Outlook and Core Earnings Per Share Target Reaffirmed
- Forest Laboratories Reports Earnings Per Share of $0.71 for Q2'08 Including $0.15 Charge Net of Tax for Licensing Charge
- Thomson Scientific Publishes 'Who Is Making The Biggest Splash?' - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
- Repros Provides Update for Regulatory Program Associated with Androxal Development
- Canon Communications Successfully Launches Medical Design & Manufacturing (MD&M) Event in Northern California
- Edgeline Holdings to Close on Its Acquisition of Intertech Bio
- OSI Pharmaceuticals Provides Additional Information About US Sales of Tarceva
- FDA MedWatch: Byetta (exenatide) and Postmarketing Reports of Acute Pancreatitis
October 17, 2007
- Cubist Pharmaceuticals Announces Exclusive Option to Acquire Illumigen Biosciences
- ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize Erbitux in Japan
- Abbott Reports 14.4 Percent Sales Growth in Third Quarter
- Allergan Announces Completion of Esprit Pharma Acquisition
- DARA BioSciences and Bayer Pharmaceuticals Corporation Sign Exclusive License Agreement
- Bausch & Lomb Announces Entry Into Agreement to Sell $650 Million of Notes
- Report Finds Major Gaps Exist in U.S. Pediatric Pandemic Preparations
- Drug-Resistant Staph Infection Appears More Widespread Than Previously Thought
- ImmunoGen, Inc. Earns Milestone with Start of SAR3419 Clinical Testing
October 18, 2007
- Baxter Reports Strong Third Quarter Sales and Earnings
- Lilly Delivers Strong Third-Quarter Results
- Lilly and MacroGenics Announce Licensing and Collaboration Agreement
- Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months
- Novartis Delivers Record Earnings in First Nine Months of 2007 Thanks to Strong Operational Performance and Divestment Gains
- Pfizer Reports Third-Quarter 2007 Results; Reconfirms 2007 and 2008 Revenue and Adjusted Diluted EPS Guidance
- Aspreva to be Acquired by Galenica For US$915 Million
- IDEX Corporation Acquires Isolation Technologies in a Strategic Expansion of Its Health and Science Technologies Segment
- inVentiv Health Provides Sales Teams Contract Update
- EPO Announces Symbicort European Combination Patent Decision
- Dong-A Pharmaceutical Co Ltd (000640 KS) Calls on Kang-Korea Alcohol Nominees at October 31 EGM to Disclose Any Agreements or Understandings They Have Regarding Their Possible Service as Dong-A Directors
October 19, 2007
- FDA Announces Revisions to Labels for Cialis, Levitra and Viagra
- Gilead Sciences Announces Third Quarter 2007 Financial Results
- King Pharmaceuticals Accelerates Strategic Shift to Maximize Long-Term Growth
- Nektar Therapeutics Issues Statement on Exubera
- Dong-A Pharmaceutical Co Ltd (000640 KS) Announces That Glass Lewis and ISS Governance Services, the Leading Proxy Voting Advisory Services, Have Recommended Their Clients Vote against Kang-Korea Alcohol Nominees at the October 31 EGM
October 22, 2007
- Adenoscan(R) Patent Lawsuits Settled
- Thousands of Medical Students Urge Schools to Eliminate Pharmaceutical Marketing Influence
- Schering-Plough Reports Financial Results for Third Quarter of 2007
- Merck Reports Double-Digit Revenue and Earnings-Per-Share Growth for Third-Quarter 2007
- Avant Immunotherapeutics, Inc. and Celldex Therapeutics, Inc. Announce Merger Agreement
- Raptor Pharmaceuticals Acquires Initial Clinical Program Establishes Subsidiary to Develop Clinical Phase Drugs
October 23, 2007
- Biogen Idec Reports Third Quarter 2007 Results
- Bentley Pharmaceuticals, Inc. Announces Plans to Separate Its Two Businesses and Explore Strategic Alternatives with Respect to Its Generics Business
- GlaxoSmithKline and Tolerx Form Worldwide Collaboration for Development and Commercialization of Novel Medication
- Genzyme Launches Cholestagel in Europe
- ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients
- Update Regarding Clinical Trials of Merck's HIV Vaccine Candidate
- Statement by Merck & Co., Inc. Regarding FDA Nonprescription Advisory Committee Review of Mevacor (lovastatin)
- Two Million Consumers Commit to Healthier Weight-Loss Approach with alli
- Delcath Voluntarily Defers Accrual in Clinical Trials
- Paramount Stockholders Approve Acquisition of Chem Rx
- Spanish Appellate Court Rules in Pfizer's Favor, Upholds Lipitor Patent
- Asuragen Enters Oncology Collaboration with Merck to Develop Pharmacogenomic Tests
- Roche Considering Legal Options In Patent Litigation Case
- Jury Rules Roche Infringes Amgen's EPO Patents
October 24, 2007
- Pharmaceutical Advertising Turns to Campaigns Dense with Symbols to Drive Memorable Advertising for the 2006-2007 TV Season
- GSK Reports Third Quarter EPS of 23.7p; Significant new Operational Excellence Programme Announced
- Q3/2007: Merck Operating Result Rises 56% to EUR 292 Million
- AAHC Examines Nation's Clinical Trials Infrastructure
- Med Opportunity Partners Leads Purchase Of St. Louis Based Active Pharmaceutical Ingredient Manufacturer Reliable Biopharmaceutical Corporation
- FDA Sends Sanofi Warning Letter for Ketek Study
October 25, 2007
- Bristol-Myers Squibb Company Reports Financial Results for the Third Quarter and First Nine Months of 2007
- FDA and Cephalon Notify Healthcare Professionals of Updates to the Warnings Section of the Prescribing Information for Provigil (modafinil)
- Study Protocols Will be Amended in Two Small Early-Phase Prasugrel Studies
- ImClone Systems Reports Third Quarter 2007 Financial Results
- Shire Launches Clinical Study Results Website
- Amgen's Third Quarter 2007 Adjusted Earnings Per Share Increased 4 Percent to $1.08
- Elan Reports Third Quarter 2007 Financial Results
- Genzyme and Sunway to Collaborate on Gene Therapy Program in China
- Novavax and Allergan Terminate Manufacturing Supply Agreement for Estrasorb
- Alcon's Third Quarter Sales Rise 11.0 Percent
- PerkinElmer Announces Expiration of Hart-Scott-Rodino Waiting Period of Proposed ViaCell Acquisition
- Barr Confirms Filing an Application With a Paragraph IV Certification for Patanol Ophthalmic Solution, 0.1%
- FDA Issues an Early Communication about an Ongoing Safety Review for Aprotinin Injection (marketed as Trasylol)
October 26, 2007
- I-Flow Announces Closing of InfuSystem Transaction
- NovaBay Pharmaceuticals Prices Initial Public Offering of Common Stock
- Kosan to Reacquire Epothilone Program From Roche
- Pfizer Announces Retirement of Vice Chairman David L. Shedlarz
- Tapestry Announces Strategy to Focus on TPI 287 Clinical Program
- Daiichi Sankyo Announces the Revisions of Financial Forecasts for FY2007
- Cortex to Provide Shareholder Update and Host Conference Call on October 31, 2007
- Aviation Upgrade Technologies Enters into Merger Agreement with OncoVista, Inc.
- Collexis Holdings Acquires SyynX Solutions, Expands Application Portfolio
- Solvay: Nine Months 2007 Results
- Former GlaxoSmithKline Executive to Lead UNC Drug Discovery Center
- FDA Establishes a Pediatric Review Committee to Consult on General Review of Pediatric Information Submitted by Sponsors
- Warburg Pincus Completes Acquisition of Bausch & Lomb
- Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
October 29, 2007
- Kyowa Hakko Interim Operating Income up 25.2%
- ChemGenex Announces Strategic Restructuring of Company to Focus on Late-Stage Cancer Portfolio
- Takeda Provides Update on Development Status of TAK-475, An Investigational Compound for Treatment of Hypercholesterolemia
- AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
- Thallion Provides Update on Shigamabs Clinical Development and U.S. Regulatory Plan
- John Edwards Introduces Proposals To Stop Misleading Drug Marketing By Standing Up To Drug Companies
- Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
- Quantum Genomics Corp Widens Net with Acquisition of Eurobiobiz SAS
- CTI Announces the FDA Allows Long Term Use of ISA247 in Isotechnika Phase 2b Clinical Program for the Prevention of Rejection Following Kidney Transplantation
- GAO: Prescription Drugs: FDA Guidance and Regulations Related to Data on Elderly Persons in Clinical Drug Trials
- Sen. Grassley Seeks Transparency in FDA Review of Heart Health Risks with Diabetes Drug
- Pfizer to Appeal German Court Decision in Lipitor Patent Case; Company Notes That Ruling Has No Immediate Commercial Impact
- MedWatch - The FDA Safety Information and Adverse Event Reporting Program
- FDA MedWatch: Use of CellCept (mycophenolate mofetil) Associated with Increased Pregnancy Loss and Congenital Malformations
October 30, 2007
- Lilly and Glenmark Pharmaceuticals Announce License Agreement
- Taisho and Pfizer Sign a Letter of Intent for Taisho's Schizophrenia Drug Candidate
- Teva Reports Third Quarter 2007 Results
- Bradley Pharmaceuticals Announces Definitive Merger Agreement with Nycomed for $20 Per Share in Cash
- Pharmos Restructures Operations in Israel
- Sepracor Inc. Announces Third Quarter 2007 Results and Planned Reduction in Operating Expenses for 2008
- Roche Extends Tender Offer for Ventana
- Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
- Quantum Genomics Corp Widens Net with Acquisition of Eurobiobiz SAS
- P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth
- Coco-Cola, Kellogg’s, Mattel and Takeda Pharmaceuticals Top the List of International Brands Guilty of Abusing Consumer Rights.
- Neurobiological Technologies Announces Pricing of Its $60 Million Common Stock Offering
- Minnesota Hormone Therapy Lawsuit Dismissed
- Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc.
- Younger Adults Increasingly Treated for Heart Disease-related Conditions
- Phase Forward Acquires Green Mountain Logic, An Innovative Provider of Software for Managing Phase I Clinical Trials
- Genentech: Open Letter
